{"id":1661270,"date":"2026-03-14T17:32:43","date_gmt":"2026-03-14T17:32:43","guid":{"rendered":"https:\/\/celebrity.land\/pt\/?p=1661270"},"modified":"2026-03-14T17:32:43","modified_gmt":"2026-03-14T17:32:43","slug":"form-4-atividade-de-negociacao-com-informacoes-privilegiadas-da-sphere-entertainment-co-arquivamento-sphr-sec","status":"publish","type":"post","link":"https:\/\/celebrity.land\/pt\/form-4-atividade-de-negociacao-com-informacoes-privilegiadas-da-sphere-entertainment-co-arquivamento-sphr-sec\/","title":{"rendered":"[Form 4] Atividade de negocia\u00e7\u00e3o com informa\u00e7\u00f5es privilegiadas da Sphere Entertainment Co. Arquivamento SPHR SEC"},"content":{"rendered":"\n<figure><\/figure>\n<\/p>\n<div id=\"filing-content-wrapper\">\n        <!-- Extra safety wrapper to contain any unclosed tags --><\/p>\n<div class=\"filing-content-inner\">\n<p>Formul\u00e1rio SEC 4 <\/p>\n<table width=\"100%\" border=\"0\" cellspacing=\"0\" cellpadding=\"4\">\n<tr>\n<td width=\"20%\" colspan=\"2\" valign=\"top\" align=\"center\" class=\"FormName\">FORMUL\u00c1RIO 4<\/td>\n<td rowspan=\"2\" width=\"60%\" valign=\"middle\" align=\"center\">\n<span class=\"FormTitle\">COMISS\u00c3O DE VALORES MOBILI\u00c1RIOS E C\u00c2MBIO DOS ESTADOS UNIDOS<\/span><br \/><span class=\"MedSmallFormText\">Washington, DC 20549<\/span><\/p>\n<p><span class=\"FormTitle\">DECLARA\u00c7\u00c3O DE ALTERA\u00c7\u00d5ES NA PROPRIEDADE BENEFICIAL<\/span><\/p>\n<p><span class=\"MedSmallFormText\">Arquivado de acordo com a Se\u00e7\u00e3o 16(a) do Securities Exchange Act de 1934<\/span><br \/><span class=\"MedSmallFormText\">ou Se\u00e7\u00e3o 30(h) da Lei de Sociedades de Investimento de 1940<\/span>\n<\/p>\n<\/td>\n<td rowspan=\"2\" width=\"20%\" valign=\"top\" align=\"center\">\n<table width=\"100%\" border=\"1\" summary=\"OMB Approval Status Box\">\n<tr>\n<td class=\"FormTextC\">APROVA\u00c7\u00c3O OMB<\/td>\n<\/tr>\n<tr>\n<td>\n<table width=\"100%\" border=\"0\" summary=\"OMB Interior Box\">\n<tr>\n<td class=\"SmallFormText\" colspan=\"3\">N\u00famero OMB:<\/td>\n<td class=\"SmallFormTextR\">3235-0287<\/td>\n<\/tr>\n<tr>\n<td class=\"SmallFormText\" colspan=\"4\">Carga m\u00e9dia estimada<\/td>\n<\/tr>\n<tr>\n<td class=\"SmallFormText\" colspan=\"3\">horas por resposta:<\/td>\n<td class=\"SmallFormTextR\">0,5<\/td>\n<\/tr>\n<\/table>\n<\/td>\n<\/tr>\n<\/table>\n<\/td>\n<\/tr>\n<tr valign=\"middle\">\n<td \/>\n<td class=\"SmallFormText\">Marque esta caixa se n\u00e3o estiver mais sujeito \u00e0 Se\u00e7\u00e3o 16. As obriga\u00e7\u00f5es do Formul\u00e1rio 4 ou do Formul\u00e1rio 5 podem continuar.<br \/>\n         <i>Ver<\/i><\/p>\n<p>                  Instru\u00e7\u00e3o 1(b).<\/td>\n<\/tr>\n<tr valign=\"middle\">\n<td \/>\n<td class=\"SmallFormText\">Marque esta caixa para indicar que uma transa\u00e7\u00e3o foi feita de acordo com um contrato, instru\u00e7\u00e3o ou plano escrito para a compra ou venda de t\u00edtulos patrimoniais do emissor que se destina a satisfazer as condi\u00e7\u00f5es de defesa afirmativa da Regra 10b5-1(c). Consulte a Instru\u00e7\u00e3o 10. <\/td>\n<\/tr>\n<\/table>\n<table width=\"100%\" border=\"1\" cellspacing=\"0\" cellpadding=\"4\">\n<tr>\n<td rowspan=\"4\" width=\"35%\" valign=\"top\">\n<span class=\"MedSmallFormText\">1. Nome e endere\u00e7o do denunciante<sup>*<\/sup><\/span><\/p>\n<hr width=\"98%\" \/>\n<hr width=\"98%\" \/>\n<span class=\"MedSmallFormText\">(Rua)<\/span><\/p>\n<hr width=\"98%\" \/>\n<\/td>\n<td width=\"35%\" valign=\"top\">\n<span class=\"MedSmallFormText\">2. Nome do Emitente <b>e<\/b> Ticker ou s\u00edmbolo de negocia\u00e7\u00e3o<br \/>\n      <\/span><br \/><span class=\"filing-link\">Esfera Entertainment Co.<\/span><br \/>\n     [ <span class=\"FormData\">SPHR<\/span> ]\n   <\/td>\n<td rowspan=\"2\" valign=\"top\">\n<span class=\"MedSmallFormText\">5. Relacionamento do(s) Denunciante(s) com o Emissor<br \/>\n      <\/span><br \/><span class=\"MedSmallFormText\">(Marque todos os aplic\u00e1veis)<\/span><\/p>\n<table border=\"0\" width=\"100%\">\n<tr>\n<td width=\"15%\" align=\"center\" \/>\n<td width=\"35%\" class=\"MedSmallFormText\">Diretor<\/td>\n<td width=\"15%\" align=\"center\" \/>\n<td width=\"35%\" class=\"MedSmallFormText\">10% Propriet\u00e1rio<\/td>\n<\/tr>\n<tr>\n<td align=\"center\"><span class=\"FormData\">X<\/span><\/td>\n<td class=\"MedSmallFormText\">Oficial (indique o t\u00edtulo abaixo)<\/td>\n<td align=\"center\" \/>\n<td class=\"MedSmallFormText\">Outro (especifique abaixo)<\/td>\n<\/tr>\n<tr>\n<td width=\"15%\" align=\"center\" \/>\n<td width=\"35%\" align=\"left\">EVP, CFO e Tesoureiro<\/td>\n<td width=\"15%\" align=\"center\" \/>\n<td width=\"35%\" align=\"left\" \/>\n<\/tr>\n<\/table>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"top\">\n<span class=\"MedSmallFormText\">3. Data da primeira transa\u00e7\u00e3o<br \/>\n         (M\u00eas\/Dia\/Ano)<\/span><br \/><span class=\"FormData\">11\/03\/2026<\/span>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"top\">\n<span class=\"MedSmallFormText\">4. Em caso de altera\u00e7\u00e3o, data do arquivamento original<br \/>\n         (M\u00eas\/Dia\/Ano)<\/span><\/td>\n<td valign=\"top\">\n<span class=\"MedSmallFormText\">6. Arquivamento individual ou conjunto\/em grupo (verifique a linha aplic\u00e1vel)<br \/>\n      <\/span><\/p>\n<table border=\"0\" width=\"100%\">\n<tr>\n<td width=\"15%\" align=\"center\"><span class=\"FormData\">X<\/span><\/td>\n<td width=\"85%\" class=\"MedSmallFormText\">Formul\u00e1rio preenchido por um Denunciante<\/td>\n<\/tr>\n<tr>\n<td width=\"15%\" align=\"center\" \/>\n<td width=\"85%\" class=\"MedSmallFormText\">Formul\u00e1rio preenchido por mais de um denunciante<\/td>\n<\/tr>\n<\/table>\n<\/td>\n<\/tr>\n<\/table>\n<table width=\"100%\" border=\"1\" cellspacing=\"0\" cellpadding=\"4\">\n<thead>\n<tr>\n<th width=\"100%\" valign=\"top\" colspan=\"11\" align=\"center\" class=\"FormTextC\"><b>Tabela I \u2013 T\u00edtulos N\u00e3o Derivativos Adquiridos, Alienados ou Beneficiados<\/b><\/th>\n<\/tr>\n<tr>\n<th width=\"36%\" valign=\"top\" rowspan=\"2\" align=\"left\" class=\"MedSmallFormText\">1. T\u00edtulo do T\u00edtulo (Instr.<br \/>\n      3)\n   <\/th>\n<th width=\"6%\" valign=\"top\" rowspan=\"2\" align=\"left\" class=\"SmallFormText\">2. Data da transa\u00e7\u00e3o<br \/>\n      (M\u00eas\/Dia\/Ano)<\/th>\n<th width=\"5%\" valign=\"top\" rowspan=\"2\" align=\"left\" class=\"SmallFormText\">2A. Data de Execu\u00e7\u00e3o Considerada, se houver<br \/>\n      (M\u00eas\/Dia\/Ano)<\/th>\n<th width=\"7%\" valign=\"top\" colspan=\"2\" align=\"left\" class=\"SmallFormText\">3. C\u00f3digo de Transa\u00e7\u00e3o (Instr.<br \/>\n      8)\n   <\/th>\n<th width=\"19%\" valign=\"top\" colspan=\"3\" align=\"left\" class=\"SmallFormText\">4. Valores Mobili\u00e1rios Adquiridos (A) ou Alienados (D) (Instr.<br \/>\n      3, 4 e 5)\n   <\/th>\n<th width=\"11%\" valign=\"top\" rowspan=\"2\" align=\"left\" class=\"SmallFormText\">5.<br \/>\n      Quantidade de t\u00edtulos de propriedade benefici\u00e1ria ap\u00f3s transa\u00e7\u00e3o(\u00f5es) relatada(s) (Instr.<br \/>\n      3 e 4)\n   <\/th>\n<th width=\"9%\" valign=\"top\" rowspan=\"2\" align=\"left\" class=\"SmallFormText\">6. Forma de Propriedade: Direta (D) ou Indireta (I) (Instr.<br \/>\n      4)\n   <\/th>\n<th width=\"8%\" valign=\"top\" rowspan=\"2\" align=\"left\" class=\"SmallFormText\">7. Natureza da Propriedade Benefici\u00e1ria Indireta (Instr.<br \/>\n      4)\n   <\/th>\n<\/tr>\n<tr>\n<th width=\"4%\" align=\"center\" class=\"SmallFormText\">C\u00f3digo<\/th>\n<th width=\"3%\" align=\"center\" class=\"SmallFormText\">V<\/th>\n<th width=\"8%\" align=\"center\" class=\"SmallFormText\">Quantia<\/th>\n<th width=\"5%\" align=\"center\" class=\"SmallFormText\">(A) ou (D)<\/th>\n<th width=\"6%\" align=\"center\" class=\"SmallFormText\">Pre\u00e7o<\/th>\n<\/tr>\n<\/thead>\n<\/table>\n<table width=\"100%\" border=\"1\" cellspacing=\"0\" cellpadding=\"4\">\n<thead>\n<tr>\n<th width=\"100%\" valign=\"top\" colspan=\"16\" align=\"center\" class=\"FormTextC\">\n<b>Tabela II \u2013 T\u00edtulos Derivativos Adquiridos, Alienados ou Beneficiados<\/b><br \/><b>(por exemplo, op\u00e7\u00f5es de venda, op\u00e7\u00f5es de compra, warrants, op\u00e7\u00f5es, t\u00edtulos convers\u00edveis)<\/b>\n<\/th>\n<\/tr>\n<tr>\n<th width=\"13%\" valign=\"top\" rowspan=\"2\" align=\"left\" class=\"SmallFormText\">1. T\u00edtulo do T\u00edtulo Derivativo (Instr.<br \/>\n      3)\n   <\/th>\n<th width=\"5%\" valign=\"top\" rowspan=\"2\" align=\"left\" class=\"SmallFormText\">2. Pre\u00e7o de Convers\u00e3o ou Exerc\u00edcio de T\u00edtulo Derivativo\n   <\/th>\n<th width=\"5%\" valign=\"top\" rowspan=\"2\" align=\"left\" class=\"SmallFormText\">3. Data da transa\u00e7\u00e3o<br \/>\n      (M\u00eas\/Dia\/Ano)<\/th>\n<th width=\"5%\" valign=\"top\" rowspan=\"2\" align=\"left\" class=\"SmallFormText\">3A. Data de Execu\u00e7\u00e3o Considerada, se houver<br \/>\n      (M\u00eas\/Dia\/Ano)<\/th>\n<th width=\"9%\" valign=\"top\" colspan=\"2\" align=\"left\" class=\"SmallFormText\">4. C\u00f3digo de Transa\u00e7\u00e3o (Instr.<br \/>\n      8)\n   <\/th>\n<th width=\"10%\" valign=\"top\" colspan=\"2\" align=\"left\" class=\"SmallFormText\">5.<br \/>\n      Quantidade de T\u00edtulos Derivativos Adquiridos (A) ou Alienados (D) (Instr.<br \/>\n      3, 4 e 5)\n   <\/th>\n<th width=\"9%\" valign=\"top\" colspan=\"2\" align=\"left\" class=\"SmallFormText\">6. Data Exerc\u00edvel e Data de Vencimento<br \/>\n      (M\u00eas\/Dia\/Ano)<\/th>\n<th width=\"17%\" valign=\"top\" colspan=\"2\" align=\"left\" class=\"SmallFormText\">7. T\u00edtulo e Quantidade dos Valores Mobili\u00e1rios Subjacentes aos Valores Mobili\u00e1rios Derivativos (Instr.<br \/>\n      3 e 4)\n   <\/th>\n<th width=\"6%\" valign=\"top\" rowspan=\"2\" align=\"left\" class=\"SmallFormText\">8. Pre\u00e7o do T\u00edtulo Derivativo (Instr.<br \/>\n      5)\n   <\/th>\n<th width=\"6%\" valign=\"top\" rowspan=\"2\" align=\"left\" class=\"SmallFormText\">9.<br \/>\n      N\u00famero de t\u00edtulos derivativos de propriedade benefici\u00e1ria ap\u00f3s transa\u00e7\u00e3o(\u00f5es) relatada(s) (Instr.<br \/>\n      4)\n   <\/th>\n<th width=\"6%\" valign=\"top\" rowspan=\"2\" align=\"left\" class=\"SmallFormText\">10. Forma de Propriedade: Direta (D) ou Indireta (I) (Instr.<br \/>\n      4)\n   <\/th>\n<th width=\"7%\" valign=\"top\" rowspan=\"2\" align=\"left\" class=\"SmallFormText\">11. Natureza da Propriedade Benefici\u00e1ria Indireta (Instr.<br \/>\n      4)\n   <\/th>\n<\/tr>\n<tr>\n<th width=\"4%\" valign=\"bottom\" align=\"center\" class=\"SmallFormText\">C\u00f3digo<\/th>\n<th width=\"4%\" valign=\"bottom\" align=\"center\" class=\"SmallFormText\">V<\/th>\n<th width=\"5%\" valign=\"bottom\" align=\"center\" class=\"SmallFormText\">(UM)<\/th>\n<th width=\"5%\" valign=\"bottom\" align=\"center\" class=\"SmallFormText\">(D)<\/th>\n<th width=\"5%\" valign=\"bottom\" align=\"center\" class=\"SmallFormText\">Data Exerc\u00edvel<\/th>\n<th width=\"4%\" valign=\"bottom\" align=\"center\" class=\"SmallFormText\">Data de validade<\/th>\n<th width=\"10%\" valign=\"bottom\" align=\"center\" class=\"SmallFormText\">T\u00edtulo<\/th>\n<th width=\"7%\" valign=\"bottom\" align=\"center\" class=\"SmallFormText\">Quantidade ou N\u00famero de A\u00e7\u00f5es<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td align=\"left\"><span class=\"SmallFormData\">Unidades de A\u00e7\u00f5es Restritas<\/span><\/td>\n<td align=\"center\" \/>\n<td align=\"center\"><span class=\"SmallFormData\">11\/03\/2026<\/span><\/td>\n<td align=\"center\" \/>\n<td align=\"center\"><span class=\"SmallFormData\">UM<\/span><\/td>\n<td align=\"center\" \/>\n<td align=\"center\"><span class=\"SmallFormData\">7.527<\/span><\/td>\n<td align=\"center\" \/>\n<td align=\"center\">\n<span class=\"SmallFormData\"><\/p>\n<p>            <\/span>\n<\/td>\n<td align=\"center\"><span class=\"SmallFormData\">15\/03\/2029<\/span><\/td>\n<td align=\"center\"><span class=\"SmallFormData\">A\u00e7\u00f5es ordin\u00e1rias classe A<\/span><\/td>\n<td align=\"center\"><span class=\"FormData\">7.527<\/span><\/td>\n<td align=\"center\">\n<span class=\"SmallFormText\">$<\/span><span class=\"SmallFormData\">0<\/span>\n<\/td>\n<td align=\"center\"><span class=\"SmallFormData\">7.527<\/span><\/td>\n<td align=\"center\"><span class=\"SmallFormData\">D<\/span><\/td>\n<td align=\"left\" \/>\n<\/tr>\n<\/tbody>\n<\/table>\n<table border=\"0\" width=\"100%\">\n<tr>\n<td class=\"MedSmallFormText\"><b>Explica\u00e7\u00e3o das respostas:<\/b><\/td>\n<\/tr>\n<tr \/>\n<tr \/>\n<\/table>\n<table width=\"100%\" border=\"0\">\n<tr>\n<td width=\"60%\" \/>\n<td width=\"20%\"><u><span class=\"FormData\">\/s\/ Mark C. Cresitello, advogado de Robert H. Langer<\/span><\/u><\/td>\n<td width=\"20%\"><u><span class=\"FormData\">13\/03\/2026<\/span><\/u><\/td>\n<\/tr>\n<tr>\n<td \/>\n<td class=\"MedSmallFormText\">** Assinatura do Denunciante<\/td>\n<td class=\"MedSmallFormText\">Data<\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\" class=\"MedSmallFormText\">Lembrete: relate em uma linha separada para cada classe de t\u00edtulos de propriedade direta ou indireta.<\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\" class=\"MedSmallFormText\">*Se o formul\u00e1rio for preenchido por mais de um denunciante,<br \/>\n                  <i>ver<\/i><\/p>\n<p>                                    Instru\u00e7\u00e3o<br \/>\n                  4<\/p>\n<p>                                    (b)(v).<\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\" class=\"MedSmallFormText\">** Distor\u00e7\u00f5es intencionais ou omiss\u00f5es de fatos constituem infra\u00e7\u00f5es criminais federais<br \/>\n                  <i>Ver<\/i><\/p>\n<p>                                    18 USC 1001 e 15 USC 78ff(a).<\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\" class=\"MedSmallFormText\">Nota: Arquive tr\u00eas c\u00f3pias deste Formul\u00e1rio, uma das quais deve ser assinada manualmente. Se o espa\u00e7o for insuficiente,<br \/>\n                  <i>ver<\/i><\/p>\n<p>                                    Instru\u00e7\u00e3o 6 para procedimento.<\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\" class=\"MedSmallFormText\"><b>As pessoas que respondem \u00e0 coleta de informa\u00e7\u00f5es contidas neste formul\u00e1rio n\u00e3o s\u00e3o obrigadas a responder, a menos que o formul\u00e1rio exiba um n\u00famero OMB atualmente v\u00e1lido.<\/b><\/td>\n<\/tr>\n<\/table>\n<\/div>\n<p>        <!-- Source Filing Link --><\/p>\n<\/div>\n<p><em>  &#8216;O artigo anterior pode incluir informa\u00e7\u00f5es divulgadas por terceiros&#8217; <\/em><\/p>\n<p><em>  &#8216;Alguns detalhes deste artigo foram extra\u00eddos da seguinte fonte www.stocktitan.net&#8217; <\/em><\/p>\n<p><em> \u2018 O artigo anterior foi obtido e traduzido do site internacional da celebrity.land   \u2019 Source Link <\/em><\/p>\n\n","protected":false},"excerpt":{"rendered":"<p>Formul\u00e1rio SEC 4 FORMUL\u00c1RIO 4 COMISS\u00c3O DE VALORES MOBILI\u00c1RIOS E C\u00c2MBIO DOS ESTADOS UNIDOSWashington, DC 20549 DECLARA\u00c7\u00c3O DE ALTERA\u00c7\u00d5ES NA PROPRIEDADE BENEFICIAL Arquivado de acordo com a Se\u00e7\u00e3o 16(a) do Securities Exchange Act de 1934ou Se\u00e7\u00e3o 30(h) da Lei de Sociedades de Investimento de 1940 APROVA\u00c7\u00c3O OMB N\u00famero OMB: 3235-0287 Carga m\u00e9dia estimada horas por [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":1661240,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":[],"jnews_primary_category":[],"jnews_override_counter":[],"footnotes":""},"categories":[45],"tags":[],"class_list":["post-1661270","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-entretenimento"],"_links":{"self":[{"href":"https:\/\/celebrity.land\/pt\/wp-json\/wp\/v2\/posts\/1661270","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celebrity.land\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celebrity.land\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celebrity.land\/pt\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/celebrity.land\/pt\/wp-json\/wp\/v2\/comments?post=1661270"}],"version-history":[{"count":1,"href":"https:\/\/celebrity.land\/pt\/wp-json\/wp\/v2\/posts\/1661270\/revisions"}],"predecessor-version":[{"id":1661271,"href":"https:\/\/celebrity.land\/pt\/wp-json\/wp\/v2\/posts\/1661270\/revisions\/1661271"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/celebrity.land\/pt\/wp-json\/wp\/v2\/media\/1661240"}],"wp:attachment":[{"href":"https:\/\/celebrity.land\/pt\/wp-json\/wp\/v2\/media?parent=1661270"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celebrity.land\/pt\/wp-json\/wp\/v2\/categories?post=1661270"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celebrity.land\/pt\/wp-json\/wp\/v2\/tags?post=1661270"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}